Clinical Trial Update: Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of AL-4943A ophthalmic solution for allergic conjunctivitis; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AL-4943A Ophthalmic Solution (AL-4943A)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2013-05-23